Adult hippocampal neurogenesis: regulation, functional implications, and contribution to disease pathology
DT Balu, I Lucki - Neuroscience & Biobehavioral Reviews, 2009 - Elsevier
It is now well established that the mammalian brain has the capacity to produce new
neurons into adulthood. One such region that provides the proper milieu to sustain …
neurons into adulthood. One such region that provides the proper milieu to sustain …
Serotonin control of central dopaminergic function: focus on in vivo microdialysis studies
V Di Matteo, G Di Giovanni, M Pierucci… - Progress in brain …, 2008 - Elsevier
In this review, the functional interactions between serotonin (5-HT) and dopamine (DA)
neuronal systems are discussed with the focus on microdialysis studies in the rodent brain …
neuronal systems are discussed with the focus on microdialysis studies in the rodent brain …
Gender-dependent consequences of chronic olanzapine in the rat: effects on body weight, inflammatory, metabolic and microbiota parameters
KJ Davey, SM O'Mahony, H Schellekens… - …, 2012 - Springer
Abstract Rationale Atypical antipsychotic drugs (AAPDs) such as olanzapine have a serious
side effect profile including weight gain and metabolic dysfunction, and a number of studies …
side effect profile including weight gain and metabolic dysfunction, and a number of studies …
Differential regulation of central BDNF protein levels by antidepressant and non-antidepressant drug treatments
DT Balu, BA Hoshaw, JE Malberg… - Brain research, 2008 - Elsevier
Antidepressant treatments have been proposed to produce their therapeutic effects, in part,
through increasing neurotrophin levels in the brain. The current experiments investigated …
through increasing neurotrophin levels in the brain. The current experiments investigated …
Aripiprazole: from pharmacological profile to clinical use
G Di Sciascio, MA Riva - Neuropsychiatric Disease and Treatment, 2015 - Taylor & Francis
Clinical experience with aripiprazole has confirmed the effectiveness and the safety of this
novel antipsychotic drug in patients with schizophrenia as well as for the treatment of mania …
novel antipsychotic drug in patients with schizophrenia as well as for the treatment of mania …
Relevance of neuropeptide Y (NPY) in psychiatry
K Eaton, FR Sallee, R Sah - Current topics in medicinal …, 2007 - ingentaconnect.com
Extensive preclinical studies suggest neuropeptide Y (NPY) to be involved in stress
regulation and coping. NPY counteracts the behavioral consequences of stress and anxiety …
regulation and coping. NPY counteracts the behavioral consequences of stress and anxiety …
Platelet haemostatic function in psychiatric disorders: Effects of antidepressants and antipsychotic drugs
A Dietrich-Muszalska, B Wachowicz - The World Journal of …, 2017 - Taylor & Francis
Objectives Platelets, the smallest anucleated blood cells, play an essential role in the first
step of complex haemostatic process. This review presents the haemostatic function of blood …
step of complex haemostatic process. This review presents the haemostatic function of blood …
A systematic review of dramatherapy interventions used to support adults with psychosis
E Melvin, M Green, E Keiller, C Parmar… - Schizophrenia Research, 2024 - Elsevier
Background Psychiatric treatment of psychosis often comprises therapeutic and
psychotropic combinations. Dramatherapy is often utilised in health services with this …
psychotropic combinations. Dramatherapy is often utilised in health services with this …
Dopamine transporter endocytic determinants: carboxy terminal residues critical for basal and PKC-stimulated internalization
E Boudanova, DM Navaroli, Z Stevens… - Molecular and Cellular …, 2008 - Elsevier
Dopamine (DA) reuptake terminates dopaminergic neurotransmission and is mediated by
DA transporters (DATs). Acute protein kinase C (PKC) activation accelerates DAT …
DA transporters (DATs). Acute protein kinase C (PKC) activation accelerates DAT …
5‐HT6 antagonists as potential treatment for cognitive dysfunction
KG Liu, AJ Robichaud - Drug Development Research, 2009 - Wiley Online Library
Among the potential therapeutic targets for the development of cognitive enhancers for AD
and schizophrenia, the 5‐HT6 receptor is of especial interest based on its localization …
and schizophrenia, the 5‐HT6 receptor is of especial interest based on its localization …